Skip to main content
Joaquin Duato, Chairman of the Board and Chief Executive Officer & Marillyn Hewson, Lead Director (photo)

Message from our leaders

  • GRI
  • 2-22

    Statement on sustainable development strategy

To our global community,

2023 was a transformational year for Johnson & Johnson.

In separating our Consumer Health business, we reoriented our company to focus on the world’s toughest health challenges through scientific innovation and technology.

Our Innovative Medicine and MedTech businesses are now operating under the Johnson & Johnson name. Together our more than 130,000 employees are building a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive, and solutions are personal.

While Johnson & Johnson evolves to address the most pressing needs of patients, our purpose remains the same. For more than 80 years, Our Credo has reminded us of our responsibilities to the people we serve: patients, doctors and nurses, employees, communities and investors.

In 2023, our Executive Committee and Board of Directors spoke with Credo stakeholders to understand their expectations for Johnson & Johnson as we enter this new chapter in our evolution. Their message was clear: Johnson & Johnson is unique in our industry, and our Health for Humanity priorities should reflect that.

Our Health for Humanity strategy reflects our focus on driving the next wave of medical innovation, while championing global health equity, empowering our employees and advancing environmental health. A key element is our use of data science and technology, which are transforming our business.

Among many highlights in 2023, we supported almost 1 million healthcare workers worldwide to connect communities to care, including training 40,000 operating room and hospital staff in resource-limited settings. In the United States, we have reached 4.5 million people of color since 2020 through community-led health programs to address racial health inequities. To advance environmental health, 87% of our global electricity needs came from renewable sources.

We are committed to continuous improvement, and we are encouraged to see our most recent ESG ratings improve across most major indices.

As a company devoted to caring for others, we know we must also care for our employees. In 2023, our 12 Employee Resource Groups engaged almost 25,000 colleagues in fostering a culture of inclusion and belonging where all perspectives, abilities and experiences are valued. We are proud of our culture of professional development, and in 2023 we hosted our first Global Learning Day and launched an AI-powered employee learning platform. We also expanded resources to support mental health and enhanced our global paid-leave benefits.

Johnson & Johnson has been a purpose-driven company for almost 140 years. Now fully focused on pharmaceuticals and medical technology, we are well-positioned to innovate across the full spectrum of healthcare, delivering the breakthroughs of tomorrow and advancing health for humanity.

Signature of Joaquin Duato, Chairman of the Board and Chief Executive Officer (signature)
Joaquin Duato Chairman of the Board and
Chief Executive Officer
Signature of Marillyn Hewson Lead Director (signature)
Marillyn Hewson Lead Director